Two Sigma Advisers’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-187,900
| Closed | -$18.6M | – | 2561 |
|
|
2024
Q3 | $18.6M | Sell |
187,900
-780,400
| -81% | -$77.1M | 0.04% | 336 |
|
|
2024
Q2 | $89.8M | Buy |
968,300
+362,300
| +60% | +$33.6M | 0.2% | 100 |
|
|
2024
Q1 | $57.5M | Buy |
606,000
+334,900
| +124% | +$31.8M | 0.13% | 159 |
|
|
2023
Q4 | $24.2M | Sell |
271,100
-65,400
| -19% | -$5.84M | 0.06% | 293 |
|
|
2023
Q3 | $24.6M | Buy |
336,500
+306,100
| +1,007% | +$22.4M | 0.06% | 264 |
|
|
2023
Q2 | $2.53M | Sell |
30,400
-1,711,500
| -98% | -$142M | 0.01% | 1073 |
|
|
2023
Q1 | $133M | Buy |
1,741,900
+788,700
| +83% | +$60.1M | 0.34% | 70 |
|
|
2022
Q4 | $79.1M | Sell |
953,200
-376,600
| -28% | -$31.3M | 0.22% | 99 |
|
|
2022
Q3 | $105M | Buy |
+1,329,800
| New | +$105M | 0.31% | 81 |
|
|
2022
Q2 | – | Sell |
-201,000
| Closed | -$18.1M | – | 2895 |
|
|
2022
Q1 | $18.1M | Sell |
201,000
-330,600
| -62% | -$29.7M | 0.05% | 345 |
|
|
2021
Q4 | $59.5M | Buy |
+531,600
| New | +$59.5M | 0.15% | 138 |
|
|
2021
Q2 | – | Sell |
-88,100
| Closed | -$12M | – | 2725 |
|
|
2021
Q1 | $12M | Buy |
+88,100
| New | +$12M | 0.03% | 511 |
|
|
2020
Q3 | – | Sell |
-82,000
| Closed | -$9.18M | – | 2654 |
|
|
2020
Q2 | $9.18M | Sell |
82,000
-374,600
| -82% | -$41.9M | 0.03% | 585 |
|
|
2020
Q1 | $35.4M | Sell |
456,600
-392,500
| -46% | -$30.4M | 0.14% | 174 |
|
|
2019
Q4 | $80.8M | Buy |
849,100
+327,200
| +63% | +$31.1M | 0.19% | 128 |
|
|
2019
Q3 | $39.8M | Sell |
521,900
-521,400
| -50% | -$39.8M | 0.1% | 240 |
|
|
2019
Q2 | $91.5M | Buy |
1,043,300
+743,500
| +248% | +$65.2M | 0.23% | 117 |
|
|
2019
Q1 | $27.1M | Buy |
299,800
+296,600
| +9,269% | +$26.9M | 0.07% | 334 |
|
|
2018
Q4 | $230K | Buy |
+3,200
| New | +$230K | ﹤0.01% | 2083 |
|